Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

 
 

CUBIST PHARMACEUTICALS INC (CBST) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $43.06 Metrics
OS: 76.3 M 4 % ROE
Market cap: $3.29 B 14 % ROIC
Net debt: $157 M 0.5 x Debt/EBITDA
EV: $3.44 B

 
TTM Valuation
EBITDA $301 M 11.4 x EV/EBITDA
EBIT $209 M 16.5 x EV/EBIT
EPS $0.74 58.2 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
Revenues1,054.4926.4754.0636.5562.1433.6294.6194.7
            Revenue growth13.8%22.9%18.5%13.2%29.6%47.2%51.3%61.4%
Cost of goods sold260.3230.1172.9140.8116.990.468.948.8
Gross profit794.1696.3581.1495.7445.3343.3225.8145.9
            Gross margin75.3%75.2%77.1%77.9%79.2%79.2%76.6%74.9%
Selling, general and administrative257.9171.8163.2143.3136.9   
Sales and marketing     85.067.756.9
Research and development477.7277.7184.5157.9170.6126.7  
General and administrative     40.731.526.7
EBITA134.8296.7145.3192.5140.790.941.44.9
            EBITA margin12.8%32.0%19.3%30.2%25.0%21.0%14.1%2.5%
Amortization of intangibles28.820.93.52.92.9   
EBIT106.0275.8141.8189.6137.890.941.44.9
            EBIT margin10.1%29.8%18.8%29.8%24.5%21.0%14.1%2.5%
Pre-tax income-43.6199.6104.8154.3119.929.537.5-0.4
Income taxes-25.145.571.860.040.3-98.41.90.0
            Tax rate57.4%22.8%68.5%38.9%33.6% 5.0%0.0%
Net income-18.6154.133.094.379.6127.935.6-0.4
            Net margin-1.8%16.6%4.4%14.8%14.2%29.5%12.1%-0.2%
 
Diluted EPS($0.27)$1.89$0.52$1.51$1.16$1.88$0.59($0.01)
Shares outstanding (diluted)68.281.462.962.768.468.060.454.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy